SourceOne Stock Info Your one source site for stock research

Company Website

Investor Relations

What’s the buzz—

message boards

Yahoo

Market Watch

Money Central

Raging Bull

Board Central

Biogen Idec Inc

BIIB

Biogen Idec Inc. is engaged in the research, development, manufacturing and commercialization of therapies. Biogen Idec has five products: AVONEX, RITUXAN and ZEVALIN, TYSABRI and AMEVIVE. AVONEX is for the treatment of relapsing forms of multiple sclerosis. RITUXAN and ZEVALIN are for the treatment of certain B-cell non-Hodgkin's lymphomas. TYSABRI, formerly known as ANTEGREN, is approved by the United States Food and Drug Administration (FDA) to treat relapsing forms of MS to reduce the frequency of clinical relapses. AMEVIVE is approved in the United States for the treatment of adult patients with moderate-to-severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.

Stock Quotes and Other Information

Nasdaq	NYSE	Msn	Yahoo	Silicon Investor
Excite	Lycos	Market Watch	Clear Station	StockHouse

SourceOne Message Board

Search for Stocks:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Alphabetical Listings by Company Name

S&P 100 S&P 500 S&P 400 Dow Jones Industrials Dow Jones Transportation Dow Jones Utilities Dow Jones Composite Nasdaq 100 Morgan Stanley Hi-Tech 35

Home